Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEF: Mass Azithromycin for Trachoma Elimination
NCT00221364Phase 4Completed
- Sponsor
- University of California, San Francisco
- Start
- Mar 2003
- Primary completion
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of azithromycin in trachoma (4 arms), sponsored by University of California, San Francisco. Primary endpoint: Prevalence of ocular chlamydia infection at 36 months. Started Mar 2003; status: completed.
02
Drugs
azithromycin
03
Conditions
trachoma
Beyond the preview
Go deeper on NCT00221364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00221364.